Immunoconjugate Therapy of Hematologic Malignancies: 68 (Cancer Treatment and Research, 68) - Image 1

£179.99

Springer Immunoconjugate Therapy of Hematologic Malignancies: 68 (Cancer Treatment and Research, 68)

Name: Immunoconjugate Therapy of Hematologic Malignancies: 68 (Cancer Treatment and Research, 68)
Brand: Springer
Price: 179.99 GBP
Availability: InStock

Infectious & Contagious Diseases

It has never been this cheap. We have no record of a lower price.

£180 today · cheaper than every other day in the last 3 months

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey

↓ Forecast
where the price is heading next

↓ Statistics
all-time high & low, recent range

↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 29 days • 29 data points (No recent data available)

Historical

Generating forecast...

Price Distribution

Price distribution over 29 days • 1 price levels

Days at Price

Price Analysis

Most common price: £180 (29 days, 100.0%)

Price range: £180 - £180

Price levels: 1 different prices over 29 days

Description

The hybridoma technique for producing monoclonal antibodies developed by Drs. Kohler and Millstein in 1975 revolutionized the field of tumor immunology. It is now clear that there are antigens associated with or restricted to human neoplasms that have biologic significance. Monoclonal antibodies have already been demonstrated to have great immunodiagnostic value, and it is anticipated that they will become a component of our therapeutic armamentarium. Most investigators in the field, however, feel the true potential of monoclonal antibodies in cancer therapy remains to be determined. Clearly the most encouraging results have been witnessed in the treatment of hematologic malignancies. This volume of Cancer Treatment and Research explores the current state of the art of immunoconjugate therapy of hematologic malignancies. The first chapter, authored by Drs. Rosen and Kuzel, reviews the current status of radioimmunotherapy of lymphoma. Results of clinical investigations utilizing radiolabeled immunoconjugates in B-cell lymphomas, T-cell lym phomas, and Hodgkin's disease are discussed. In addition, obstacles to effective antibody therapy are highlighted and toxicities are summarized. Chapter 2, written by Drs. Sgouros and Scheinberg, critiques the treat ment of leukemia with radiolabeled monoclonal antibodies. In this chapter, the unique features of leukemia that make it particularly suitable for radio immunotherapy are discussed, an overview of selected clinical trials is presented, and a treatment planning approach to radioimmunotherapy in corporating biologic and physical parameters is reviewed.

Product Specifications

Brand: Springer
Format: hardcover
ASIN: 0792322703
Category: Books > Subjects > Health, Family & Lifestyle > Medical & Healthcare Practitioners > Internal Medicine > Diseases & Disorders > Infectious & Contagious Diseases
Domain: Amazon UK
Release Date: 30 September 1993
Listed Since: 15 December 2006

Barcode

No barcode data available

Springer Immunoconjugate Therapy of Hematologic Malignancies: 68 (Cancer Treatment and Research, 68)

It has never been this cheap. We have no record of a lower price.

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Barcode

Similar Products You Might Like

Gene and Cellular Immunotherapy for Cancer (Cancer Drug Discovery and Development)

CAR T-Cell, An Issue of Hematology/Oncology Clinics of North America: Volume 37-6 (The Clinics: Internal Medicine, Volume 37-6)

Resistance to Ibritumomab in Lymphoma: 18 (Resistance to Targeted Anti-Cancer Therapeutics, 18)

The MD Anderson Manual of Medical Oncology, Fourth Edition

Diagnostic and Therapeutic Advances in Hematologic Malignancies: 99 (Cancer Treatment and Research, 99)

Innovative Leukemia and Lymphoma Therapy: 35 (Basic and Clinical Oncology)

Malignant Lymphomas and Hodgkin’s Disease: Experimental and Therapeutic Advances: Proceedings of the Second International Conference on Malignant ... – 16, 1984: 32 (Developments in Oncology, 32)

Malignant Lymphomas and Hodgkin’s Disease: Experimental and Therapeutic Advances: Proceedings of the Second International Conference on Malignant ... – 16, 1984: 32 (Developments in Oncology, 32)

Consulting Hematology and Oncology Handbook

Clinical Malignant Hematology

A Beginner's Guide to Targeted Cancer Treatments and Cancer Immunotherapy

Current Immunotherapeutic Strategies in Cancer: 214 (Recent Results in Cancer Research, 214)

Cancer Therapy with Radiolabeled Antibodies

Chronic and Acute Leukemias in Adults: 26 (Cancer Treatment and Research, 26)

Cancer Therapy: Monoclonal Antibodies, Lymphokines New Developments in Surgical Oncology and Chemo- and Hormonal Therapy

Leukemias

Chemotherapy for Leukemia: Novel Drugs and Treatment

Antibody-Drug Conjugates: The 21st Century Magic Bullets for Cancer: 17 (AAPS Advances in the Pharmaceutical Sciences Series, 17)

CHRONIC MYELOID LEUKEMIA FROM DAILY MA: From Daily Management to Complicated Issues (Cancer Etiology, Diagnosis and Treatments)

Cancer Consult: Expertise in Clinical Practice, Volume 2: Neoplastic Hematology & Cellular Therapy

Hodgkin’s Disease in Children: Controversies and Current Practice: 41 (Cancer Treatment and Research)

Tumor Immunology: Methods and Protocols: 1393 (Methods in Molecular Biology, 1393)

Immunotherapy in Translational Cancer Research (Translational Oncology)

Springer Hematologic Cancers: Molecular Pathobiology to Therapy